Biofrontera's IPO

Biofrontera raised a round of funding on February 14, 2018. Investors include Public.

Biofrontera is an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions …

Articles about Biofrontera's IPO: